Cash Flow Statement

Acquisitions Amortization Amortization Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased Wages, Salaries and Other

Cellebrite DI (CLBT) Shares Issued (2021 - 2025)

Cellebrite DI's Shares Issued history spans 5 years, with the latest figure at $1.3 million for Q4 2025.

Quarterly Shares Issued rose 35.32% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Dec 2025, up 48.21% year-over-year, with the annual reading at $20.1 million for FY2025, 500.99% up from the prior year.
Shares Issued came in at $1.3 million for Q4 2025, up from $1.3 million in the prior quarter.
In the past five years, Shares Issued ranged from a high of $3.6 million in Q1 2022 to a low of $610000.0 in Q2 2023.
The 5-year median for Shares Issued is $904000.0 (2021), against an average of $1.1 million.
Year-over-year, Shares Issued crashed 82.8% in 2023 and then soared 58.99% in 2025.
Cellebrite DI's Shares Issued stood at $944000.0 in 2021, then crashed by 30.4% to $657000.0 in 2022, then grew by 7.0% to $703000.0 in 2023, then soared by 38.55% to $974000.0 in 2024, then skyrocketed by 35.32% to $1.3 million in 2025.
Per Business Quant, the three most recent readings for CLBT's Shares Issued are $1.3 million (Q4 2025), $1.3 million (Q3 2025), and $1.2 million (Q2 2025).